Takeda's Stock Surge Puts Valuation in Spotlight: Is the Pharma Giant Overpriced or Undervalued?
Takeda Pharmaceutical's (TSE:4502) recent share price rally has ignited a debate among investors. With the stock closing at ¥5,242, analysts are divided on its true worth, presenting a complex picture of fair value signals and future growth prospects.